Uterine, Fetal Cerebral Doppler and Oligohydramnios to Predict Abnormal Heart Rate Tracings in Po… (NCT03703037) | Clinical Trial Compass
CompletedNot Applicable
Uterine, Fetal Cerebral Doppler and Oligohydramnios to Predict Abnormal Heart Rate Tracings in Postterm Pregnancies
Mexico227 participantsStarted 2016-01-01
Plain-language summary
Objective: To estimate the value of uterine, fetal cerebral Doppler and oligohydramnios to predict abnormal fetal heart rate tracings in pregnancies at or beyond 41 weeks
Who can participate
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Singleton pregnancy
* Gestational age of at least 287 days (41 weeks)
* Low risk pregnancy (defined as the absence of maternal or fetal complications other than postterm pregnancy)
Exclusion Criteria:
* Twin or multiple gestation
* Uncertain gestational age
* Non vertex presentation
* Estimated fetal weight below the 10th percentile for gestational age (Hadlock´s formula)
* Fetal macrosomia (estimated fetal weight ≥ 4 Kilos) diagnosed by clinical measurement (Johnson´s technique) or ultrasound measurement (Hadlock´s formula).
* Fetal abnormalities found on routine anomaly scan.
* Maternal medical disorder (preeclampsia, chronic hypertension, diabetes, lupus, hyperthyroidism)
* Prelabour rupture of membranes
* Antepartum hemorrhage
* Any fetopelvic disproportion that could create dystocia during labor.
What they're measuring
1
Category III fetal heart rate tracings
Timeframe: 24 hours
Trial details
NCT IDNCT03703037
SponsorHospital Universitario Dr. Jose E. Gonzalez